Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertension

Platelet aggregation and activation in CTEPH encourage the formation of NETs, which advances the disease and prolongs thrombus. Right heart insufficiency and hemodynamic markers had a strong correlation with PAD4 and NOX2 levels, indicating that these biomarkers may be employed to assess the severity and prognosis of CTEPH disease and offer a fresh approach to targeted treatment. The results highlight the need for additional study to elucidate platelet-mediated pathways and create therapies for CTEPH that target platelets.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2025-10-10
DOI
https://doi.org/10.1186/s12967-025-06891-8
Citations
2
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertension

Yuhan Li, Han Tian, Qiang Huang, Zhenguo Zhai et al.
2 citations
Journal of Translational Medicine
Pulmonary Hypertension Research and Treatments
3.04
article

Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertension

Yuhan Li, Han Tian, Qiang Huang, Zhenguo Zhai, Shiqing Xu, Yishan Li, Kuangxun Li, Peiran B Yang, Jixiang Liu, Xiaofan Ji, Min Liu, mengjie Duo, Ran Miao, Zhu Zhang, Jie Li, Haobo Li, Jing Wen, Xincheng Li, Lu Sun, Ximei Niu, Wanmu Xie, Bingzhang Zou, Jinzhi Wang
article en
2 citations

Abstract

Platelet aggregation and activation in CTEPH encourage the formation of NETs, which advances the disease and prolongs thrombus. Right heart insufficiency and hemodynamic markers had a strong correlation with PAD4 and NOX2 levels, indicating that these biomarkers may be employed to assess the severity and prognosis of CTEPH disease and offer a fresh approach to targeted treatment. The results highlight the need for additional study to elucidate platelet-mediated pathways and create therapies for CTEPH that target platelets.

Journal of Translational MedicineVol. 23(1)
Nanchang University (CN), Xinjiang Medical University (CN), Shanxi Medical University (CN), Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), China-Japan Friendship Hospital (CN), First Affiliated Hospital of Jiangxi Medical College (CN), Tumor Hospital of Xinjiang Medical University (CN), Wuhan Sixth Hospital (CN), First Affiliated Hospital of Nanchang University (CN)
National Natural Science Foundation of China, Chinese Academy of Medical Sciences, National Key Research and Development Program of China
Openalex Percentile: Top 8%
Pulmonary Hypertension Research and Treatments
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.